MXPA05008785A - Esteres de polietilen glicol activados. - Google Patents
Esteres de polietilen glicol activados.Info
- Publication number
- MXPA05008785A MXPA05008785A MXPA05008785A MXPA05008785A MXPA05008785A MX PA05008785 A MXPA05008785 A MX PA05008785A MX PA05008785 A MXPA05008785 A MX PA05008785A MX PA05008785 A MXPA05008785 A MX PA05008785A MX PA05008785 A MXPA05008785 A MX PA05008785A
- Authority
- MX
- Mexico
- Prior art keywords
- esters
- oxalate
- polyethylene glycol
- carbonate
- activated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
La presente invencion se refiere a la preparacion de esteres polietilenglicol carbonato activos utiles para la pegilacion de peptidos y proteinas biologicamente activos y farmaceuticamente utiles; la invencion implica el uso de esteres carbonato y oxalato activados en la formacion de esteres activos carbonato mixtos de polietilenglicol que despues reaccionan con un conector o directamente con un peptido proteina diana.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44835403P | 2003-02-19 | 2003-02-19 | |
PCT/IB2004/000424 WO2004074345A2 (en) | 2003-02-19 | 2004-02-13 | Carbonate esters of polyethylene glycol activated by means of oxalate esters |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05008785A true MXPA05008785A (es) | 2005-10-18 |
Family
ID=32908577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05008785A MXPA05008785A (es) | 2003-02-19 | 2004-02-13 | Esteres de polietilen glicol activados. |
Country Status (9)
Country | Link |
---|---|
US (1) | US7094872B2 (es) |
EP (1) | EP1597299A2 (es) |
JP (1) | JP2006517995A (es) |
AR (1) | AR043216A1 (es) |
BR (1) | BRPI0407511A (es) |
CA (1) | CA2515612A1 (es) |
MX (1) | MXPA05008785A (es) |
TW (1) | TW200426155A (es) |
WO (1) | WO2004074345A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1259563T4 (en) | 1999-12-22 | 2016-11-21 | Nektar Therapeutics | PROCEDURE FOR PREPARING 1-BENZOTRIAZOLYL CARBONATE ESTERS OF WATER SOLUBLE POLYMERS |
ATE371680T1 (de) | 2002-01-16 | 2007-09-15 | Biocompatibles Uk Ltd | Polymerkonjugate |
GB0301014D0 (en) * | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
ITPD20040159A1 (it) * | 2004-06-21 | 2004-09-21 | Univ Degli Studi Trieste | Derivati bifunzionali del polietilenglicole loro preparazione e uso. |
US8133707B2 (en) * | 2006-01-17 | 2012-03-13 | Enzon Pharmaceuticals, Inc. | Methods of preparing activated polymers having alpha nitrogen groups |
JP2007209543A (ja) * | 2006-02-09 | 2007-08-23 | Hidetoshi Tsuchida | 表面修飾アルブミンからなる固相膜および酸素吸着膜 |
CA2648582C (en) | 2006-04-07 | 2016-12-06 | Nektar Therapeutics Al, Corporation | Conjugates of an anti-tnf-alpha antibody |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342832A (en) * | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
US5618697A (en) * | 1982-12-10 | 1997-04-08 | Novo Nordisk A/S | Process for preparing a desired protein |
US5122614A (en) * | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
WO1992020371A1 (en) * | 1991-05-10 | 1992-11-26 | Celtrix Pharmaceuticals, Inc. | Targeted delivery of bone growth factors |
US5281698A (en) * | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
US5650234A (en) * | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US6180095B1 (en) * | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
GB0013810D0 (en) * | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
-
2004
- 2004-02-13 BR BRPI0407511-0A patent/BRPI0407511A/pt not_active IP Right Cessation
- 2004-02-13 EP EP04710945A patent/EP1597299A2/en not_active Withdrawn
- 2004-02-13 JP JP2006502450A patent/JP2006517995A/ja not_active Withdrawn
- 2004-02-13 WO PCT/IB2004/000424 patent/WO2004074345A2/en active Application Filing
- 2004-02-13 MX MXPA05008785A patent/MXPA05008785A/es not_active Application Discontinuation
- 2004-02-13 CA CA002515612A patent/CA2515612A1/en not_active Abandoned
- 2004-02-18 TW TW093103934A patent/TW200426155A/zh unknown
- 2004-02-18 AR ARP040100501A patent/AR043216A1/es unknown
- 2004-02-19 US US10/782,268 patent/US7094872B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2515612A1 (en) | 2004-09-02 |
AR043216A1 (es) | 2005-07-20 |
EP1597299A2 (en) | 2005-11-23 |
WO2004074345A2 (en) | 2004-09-02 |
US7094872B2 (en) | 2006-08-22 |
TW200426155A (en) | 2004-12-01 |
WO2004074345A3 (en) | 2005-01-20 |
BRPI0407511A (pt) | 2006-02-14 |
US20040162388A1 (en) | 2004-08-19 |
JP2006517995A (ja) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119243T1 (el) | Φαρμακοτεχνικες μορφες ανταγωνιστη του vegf | |
EP2298331A3 (en) | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins | |
AU2003228962A1 (en) | Ferritin fusion proteins for use in vaccines and other applications | |
CY1114244T1 (el) | Σκευασματα ανταγωνιστη vegf καταλληλα για ενδοϋαλωδη χορηγηση | |
IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
BRPI0406605B8 (pt) | conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo | |
EA200500644A1 (ru) | Высокоэффективные способные к слиянию везикулы, способ их получения и фармацевтическая композиция, их содержащая | |
EP2517721A3 (en) | Treatment of T-cell mediated diseases | |
WO2005021579A3 (en) | Epo mimetic peptides and fusion proteins | |
WO2003028757A1 (fr) | Nouvelle methode pour induire des lymphocytes t specifiques d'antigenes | |
WO2004111081A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
WO2002055098A3 (en) | Latency associated peptide for providing latency to pharmaceutically active proteins | |
WO2004074486A3 (en) | Fusion proteins of interferon alpha muteins with improved properties | |
DE60236796D1 (de) | Verzweigte polyalkylenglykole | |
BR0009472A (pt) | Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas | |
MXPA05008785A (es) | Esteres de polietilen glicol activados. | |
EP2083018A3 (en) | Compositions and methods relating to STOP-1 | |
MXPA05009135A (es) | Formulaciones liquidas de las proteinas de union del factor necrosis del tumor. | |
TW200722521A (en) | Novel bioconjugation reactions for acylating polyethylene glycol reagents | |
WO2005072766A3 (en) | Peptides that bind to hsp90 proteins | |
MY136546A (en) | A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component | |
ATE474589T1 (de) | Angiogene peptide und ihre verwendungen | |
NZ591827A (en) | Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject | |
WO2003017938A3 (en) | Conjugates targeted to target receptors | |
IL193310A0 (en) | Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |